Proteolytic regulatory mechanism of chemerin bioactivity

被引:62
作者
Du, Xiao-Yan [1 ]
Leung, Lawrence L. K. [1 ,2 ]
机构
[1] Stanford Univ, Sch Med, Div Hematol, Stanford, CA 94305 USA
[2] VA Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA
关键词
chemerin; proteolysis; chemotactic; inflammation; PLASMACYTOID DENDRITIC CELLS; FACTOR-I; CARBOXYPEPTIDASE-N; RECEPTOR; INFLAMMATION; CHEMR23; SKIN; FACTOR-1-ALPHA; IDENTIFICATION; ADIPOKINE;
D O I
10.1093/abbs/gmp091
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chemerin is a novel chemoattractant recognized by chemokine-like receptor 1 (CMKLR1), a serpentine receptor expressed primarily by plasmacytoid dendritic cells, natural killer cells, and macrophages. Human prochemerin circulates in plasma as an inactive precursor. Its chemotactic activity is expressed upon cleavage of the C-terminal amino acid residues by proteases of the coagulation, fibrinolytic, and inflammatory system. The C-terminal cleavage site of prochemerin is highly conservative, indicating that the proteolytic regulation of chemerin bioactivity is a common mechanism undertaken by different species. In this review, we summarized chemerin-proteases interactions, chemerin receptors, and their importance in normal and pathologic conditions.
引用
收藏
页码:973 / 979
页数:7
相关论文
共 46 条
  • [1] Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment
    Albanesi, Cristina
    Scarponi, Claudia
    Pallotta, Sabatino
    Daniele, Roberta
    Bosisio, Daniela
    Madonna, Stefania
    Fortugno, Paola
    Gonzalvo-Feo, Safiye
    Franssen, Jean-Denis
    Parmentier, Marc
    De Pita, Ornella
    Girolomoni, Giampiero
    Sozzani, Silvano
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2009, 206 (01) : 249 - 258
  • [2] Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1
    Arita, M
    Bianchini, F
    Aliberti, J
    Sher, A
    Chiang, N
    Hong, S
    Yang, R
    Petasis, NA
    Serhan, CN
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (05) : 713 - 722
  • [3] The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes
    Balabanian, K
    Lagane, B
    Infantino, S
    Chow, KYC
    Harriague, J
    Moepps, B
    Arenzana-Seisdedos, F
    Thelen, M
    Bachelerie, F
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (42) : 35760 - 35766
  • [4] The genetic design of signaling cascades to record receptor activation
    Barnea, Gilad
    Strapps, Walter
    Herrada, Gilles
    Berman, Yemiliya
    Ong, Jane
    Kloss, Brian
    Axel, Richard
    Lee, Kevin J.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (01) : 64 - 69
  • [5] Chemerin is a novel adipokine associated with obesity and metabolic syndrome
    Bozaoglu, Kiymet
    Bolton, Kristy
    McMillan, Janine
    Zimmet, Paul
    Jowett, Jeremy
    Collier, Greg
    Walder, Ken
    Segal, David
    [J]. ENDOCRINOLOGY, 2007, 148 (10) : 4687 - 4694
  • [6] Regulation of hematopoiesis by chemokine family members
    Broxmeyer, HE
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2001, 74 (01) : 9 - 17
  • [7] CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers
    Burger, J. A.
    Peled, A.
    [J]. LEUKEMIA, 2009, 23 (01) : 43 - 52
  • [8] Synthetic chemerin-derived peptides suppress inflammation through ChemR23
    Cash, Jenna L.
    Hart, Rosie
    Russ, Andreas
    Dixon, John P. C.
    Colledge, William H.
    Doran, Joanne
    Hendrick, Alan G.
    Carlton, Mark B. L.
    Greaves, David R.
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 205 (04) : 767 - 775
  • [9] Identification of carboxypeptidase N as an enzyme responsible for C-terminal cleavage of stromal cell-derived factor-1α in the circulation
    Davis, DA
    Singer, KE
    Sierra, MD
    Narazaki, M
    Yang, FQ
    Fales, HM
    Yarchoan, R
    Tosato, G
    [J]. BLOOD, 2005, 105 (12) : 4561 - 4568
  • [10] Delgado MB, 2001, EUR J IMMUNOL, V31, P699, DOI 10.1002/1521-4141(200103)31:3<699::AID-IMMU699>3.0.CO